<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">urmj</journal-id><journal-title-group><journal-title xml:lang="ru">Уральский медицинский журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Ural Medical Journal</trans-title></trans-title-group></journal-title-group><issn pub-type="epub">2949-4389</issn><publisher><publisher-name>Ural State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.52420/umj.24.5.19</article-id><article-id custom-type="edn" pub-id-type="custom">DIRXXY</article-id><article-id custom-type="elpub" pub-id-type="custom">urmj-1968</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Оригинальные статьи | Original articles</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Original articles</subject></subj-group></article-categories><title-group><article-title>Особенности социального статуса и наличие факторов риска у больных туберкулезом легких с сахарным диабетом</article-title><trans-title-group xml:lang="en"><trans-title>Features of Social Status and The Presence of Risk Factors in Lung Tuberculosis Patients with Diabetes Mellitus</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6787-2362</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Черных</surname><given-names>Н. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Chernyh</surname><given-names>N. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Черных Наталья Александровна — кандидат медицинских наук, старший научный сотрудник отдела фтизиатрии.</p><p>Москва</p></bio><bio xml:lang="en"><p>Natalya A. Chernyh — Candidate of Sciences (Medicine), Senior Researcher of the Department of Phthisiology, Central Tuberculosis Research Institute.</p><p>Moscow</p></bio><email xlink:type="simple">natadok@inbox.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8745-7940</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Чумоватов</surname><given-names>Н. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Chumovatov</surname><given-names>N. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Чумоватов Никита Владимирович — кандидат медицинских наук, научный сотрудник отдела фтизиатрии.</p><p>Москва</p></bio><bio xml:lang="en"><p>Nikita V. Chumovatov — Candidate of Sciences (Medicine), Researcher of the Department of Phthisiology, Central Tuberculosis Research Institute.</p><p>Moscow</p></bio><email xlink:type="simple">Necro5412@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4427-3804</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Комиссарова</surname><given-names>О. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Komissarova</surname><given-names>O. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Комиссарова Оксана Геннадьевна — доктор медицинских наук, доцент, заместитель директора по научной и лечебной работе, ЦНИИТ; профессор кафедры фтизиатрии, институт клинической медицины, РНИМУ им. Н.И. Пирогова.</p><p>Москва</p></bio><bio xml:lang="en"><p>Oksana G. Komissarova — Doctor of Sciences (Medicine), Associate Professor, Deputy Director for Scientific and Medical Work, Central Tuberculosis Research Institute; Professor of the Department of Phthisiology, Institute of Clinical Medicine, Pirogov Russian National Research Medical University.</p><p>Moscow</p></bio><email xlink:type="simple">oksana.komissarova.72@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0240-5514</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Романов</surname><given-names>В. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Romanov</surname><given-names>V. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Романов Владимир Викторович — доктор медицинских наук, профессор, руководитель отдела фтизиатрии.</p><p>Москва</p></bio><bio xml:lang="en"><p>Vladimir V. Romanov — Doctor of Sciences (Medicine), Professor, Head of the Department of Phthisiology, Central Tuberculosis Research Institute.</p><p>Moscow</p></bio><email xlink:type="simple">romanov-vladimir-vik@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Центральный научно-исследовательский институт туберкулеза</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Central Tuberculosis Research Institute</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Центральный научно-исследовательский институт туберкулеза; Российский национальный исследовательский медицинский университет имени Н.И. Пирогова</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Central Tuberculosis Research Institute; Pirogov Russian National Research Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>02</day><month>11</month><year>2025</year></pub-date><volume>24</volume><issue>5</issue><elocation-id>19–28</elocation-id><permissions><copyright-statement>Copyright &amp;#x00A9; Черных Н.А., Чумоватов Н.В., Комиссарова О.Г., Романов В.В., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Черных Н.А., Чумоватов Н.В., Комиссарова О.Г., Романов В.В.</copyright-holder><copyright-holder xml:lang="en">Chernyh N.A., Chumovatov N.V., Komissarova O.G., Romanov V.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.umjusmu.ru/jour/article/view/1968">https://www.umjusmu.ru/jour/article/view/1968</self-uri><abstract><sec><title>Введение</title><p>Введение. Несмотря на большое влияние сахарного диабета (СД) на течение туберкулезного (ТБ) процесса, в настоящее время имеют место и другие факторы, способствующие повышенному риску развития и более тяжелого течения ТБ, которым уделяется недостаточное внимание. Особую роль в развитии и течении ТБ-процесса могут играть и особенности социального статуса.</p><p>Цель исследования — изучить наличие факторов риска, влияющих на развитие и течение ТБ-процесса, и особенности социального статуса среди больных ТБ легких в сочетании с СД.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. Всего в исследование включено 322 больных ТБ легких, которые распределены на 2 группы: 1 — в сочетании с СД (n = 173); 2 — без СД (n = 149).</p></sec><sec><title>Результаты</title><p>Результаты. Установлено, что среди больных с СД чаще наблюдаются больные пенсионеры, а также имеющие постоянное рабочее место, тогда как в группе без СД преобладают безработные лица. При изучении других факторов риска отмечено, что среди больных ТБ в сочетании с СД достоверно чаще наблюдается злоупотребление алкоголем и прекращение противотуберкулезного лечения по инициативе пациента.</p></sec><sec><title>Обсуждение</title><p>Обсуждение. Таким образом, у больных с СД ТБ протекает тяжелее, также эта группа пациентов с высокой частотой подвержена другим факторам риска. Полученные данные указывают на необходимость в установке этих факторов и разработке подходов в их контроле и устранении.</p></sec><sec><title>Заключение</title><p>Заключение. СД является важным фактором риска развития и более тяжелого течения ТБ легких. Однако другим факторам риска в настоящее время уделяется недостаточное внимание. Кроме того, на риск развития и течение ТБ могут влиять особенности социального статуса, которые различаются у больных ТБ легких с СД и без него.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Introduction</title><p>Introduction. Despite the significant impact of diabetes mellitus on the development and more severe course of the tuberculosis process, there are currently other significant risk factors that receive insufficient attention.</p><p>The purpose of the study is to investigate the presence of significant risk factors and social status characteristics among patients with pulmonary tuberculosis combined with diabetes mellitus.</p></sec><sec><title>Materials and methods</title><p>Materials and methods. A total of 322 patients with pulmonary tuberculosis were included in the study, which were divided into 2 groups: 1 — combination with diabetes mellitus (n = 173); 2 — without diabetes mellitus (n = 149).</p></sec><sec><title>Results</title><p>Results. Thus, it was found that among patients with diabetes, pensioners are more likely to be sick, as well as those who have a permanent job, whereas the unemployed predominate in the group without diabetes. When studying other significant risk factors, it was noted that alcohol abuse and withdrawal from treatment are significantly more common among patients with tuberculosis in combination with diabetes mellitus.</p></sec><sec><title>Discussion</title><p>Discussion. Thus, it is worth noting that tuberculosis is more severe in patients with diabetes mellitus, and it should also be noted that patients with diabetes mellitus are highly susceptible to other significant risk factors.</p></sec><sec><title>Conclusion</title><p>Conclusion. Diabetes mellitus is an important risk factor for the development and more severe course of pulmonary tuberculosis. However, other risk factors are currently receiving insufficient attention. In addition, the risk of developing and the course of tuberculosis may be influenced by the characteristics of social status, which differ between patients with pulmonary tuberculosis with and without diabetes mellitus.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>туберкулез</kwd><kwd>сахарный диабет</kwd><kwd>факторы риска</kwd><kwd>социальный статус</kwd><kwd>лекарственная устойчивость</kwd></kwd-group><kwd-group xml:lang="en"><kwd>tuberculosis</kwd><kwd>diabetes mellitus</kwd><kwd>risk factors</kwd><kwd>social status</kwd><kwd>drug resistance</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Adane HT, Howe RC, Wassie L, Magee MJ. Diabetes mellitus is associated with an increased risk of unsuccessful treatment outcomes among drug-susceptible tuberculosis patients in Ethiopia: A prospective health facility-based study. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases. 2023;31:100368. DOI: https://doi.org/10.1016/j.jctube.2023.100368.</mixed-citation><mixed-citation xml:lang="en">Adane HT, Howe RC, Wassie L, Magee MJ. Diabetes mellitus is associated with an increased risk of unsuccessful treatment outcomes among drug-susceptible tuberculosis patients in Ethiopia: A prospective health facility-based study. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases. 2023;31:100368. DOI: https://doi.org/10.1016/j.jctube.2023.100368.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Al Amri S, Singh J, Al Balushi L, Al Ghafri T, Al Balushi MN, Al Marbouai H, et al. Prevalence and associated factors of diabetes mellitus type 2 among tuberculosis patients in Muscat, Oman, 2017–2020. Oman Medical Journal. 2023;38(4):e526. DOI: https://doi.org/10.5001/omj.2023.82.</mixed-citation><mixed-citation xml:lang="en">Al Amri S, Singh J, Al Balushi L, Al Ghafri T, Al Balushi MN, Al Marbouai H, et al. Prevalence and associated factors of diabetes mellitus type 2 among tuberculosis patients in Muscat, Oman, 2017–2020. Oman Medical Journal. 2023;38(4):e526. DOI: https://doi.org/10.5001/omj.2023.82.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Li M, Chen T, Hua Z, Yan H, Wang D, Li Z, et al. Global, regional, and national prevalence of diabetes mellitus in patients with pulmonary tuberculosis: A systematic review and meta-analysis. Diabetology and Metabolic Syndrome. 2021;13(1):127. DOI: https://doi.org/10.1186/s13098-021-00743-3.</mixed-citation><mixed-citation xml:lang="en">Li M, Chen T, Hua Z, Yan H, Wang D, Li Z, et al. Global, regional, and national prevalence of diabetes mellitus in patients with pulmonary tuberculosis: A systematic review and meta-analysis. Diabetology and Metabolic Syndrome. 2021;13(1):127. DOI: https://doi.org/10.1186/s13098-021-00743-3.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Chumovatov NV, Komissarova OG, Antonov NS, Sakharova GM. Modern issues of lung tuberculosis and diabetes mellitus on the tobacco consumption background in the world and the Russian Federation. Russian Journal of Preventive Medicine. 2024;27(4):97–102. (In Russ.). DOI: https://doi.org/10.17116/profmed20242704197.</mixed-citation><mixed-citation xml:lang="en">Chumovatov NV, Komissarova OG, Antonov NS, Sakharova GM. Modern issues of lung tuberculosis and diabetes mellitus on the tobacco consumption background in the world and the Russian Federation. Russian Journal of Preventive Medicine. 2024;27(4):97–102. (In Russ.). DOI: https://doi.org/10.17116/profmed20242704197.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Wang CS, Yang CJ, Chen HC, Chuang SH, Chong IW, Hwang JJ, et al. Impact of type 2 diabetes on manifestations and treatment outcome of pulmonary tuberculosis. Epidemiology and Infection. 2009;137(2):203–210. DOI: https://doi.org/10.1017/S0950268808000782.</mixed-citation><mixed-citation xml:lang="en">Wang CS, Yang CJ, Chen HC, Chuang SH, Chong IW, Hwang JJ, et al. Impact of type 2 diabetes on manifestations and treatment outcome of pulmonary tuberculosis. Epidemiology and Infection. 2009;137(2):203–210. DOI: https://doi.org/10.1017/S0950268808000782.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Shewade HD, Jeyashree K, Mahajan P, Shah AN, Kirubakaran R, Rao R, et al. Effect of glycemic control and type of diabetes treatment on unsuccessful TB treatment outcomes among people with TB-Diabetes: A systematic review. PLoS One. 2017;12(10):e0186697. DOI: https://doi.org/10.1371/journal.pone.0186697.</mixed-citation><mixed-citation xml:lang="en">Shewade HD, Jeyashree K, Mahajan P, Shah AN, Kirubakaran R, Rao R, et al. Effect of glycemic control and type of diabetes treatment on unsuccessful TB treatment outcomes among people with TB-Diabetes: A systematic review. PLoS One. 2017;12(10):e0186697. DOI: https://doi.org/10.1371/journal.pone.0186697.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Anyanwu MO, Ajumobi OO, Afolabi NB, Usman A, Kehinde A. Diabetes mellitus and its associated factors among patients with tuberculosis attending directly observed treatment centres in Oyo State, Nigeria: A cross-sectional evaluation. BMJ Open. 2022;12(4): e059260. DOI: https://doi.org/10.1136/bmjopen-2021-059260.</mixed-citation><mixed-citation xml:lang="en">Anyanwu MO, Ajumobi OO, Afolabi NB, Usman A, Kehinde A. Diabetes mellitus and its associated factors among patients with tuberculosis attending directly observed treatment centres in Oyo State, Nigeria: A cross-sectional evaluation. BMJ Open. 2022;12(4): e059260. DOI: https://doi.org/10.1136/bmjopen-2021-059260.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Khattak M, Rehman AU, Muqaddas T, Hussain R, Rasool MF, Saleem Z, et al. Tuberculosis (TB) treatment challenges in TB-diabetes comorbid patients: A systematic review and meta-analysis. Annals of Medicine. 2024;56(1):2313683. DOI: https://doi.org/10.1080/07853890.2024.2313683.</mixed-citation><mixed-citation xml:lang="en">Khattak M, Rehman AU, Muqaddas T, Hussain R, Rasool MF, Saleem Z, et al. Tuberculosis (TB) treatment challenges in TB-diabetes comorbid patients: A systematic review and meta-analysis. Annals of Medicine. 2024;56(1):2313683. DOI: https://doi.org/10.1080/07853890.2024.2313683.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Komissarova OG, Abdullaev RYu, Aleshina SV. Approaches to selection of optimal chemotherapy regimens in tuberculosis patients with concurrent diabetes mellitus. Tuberculosis and Lung Diseases. 2023; 101(5):31–35 (In Russ.). DOI: https://doi.org/10.58838/2075-1230-2023-101-5-31-35.</mixed-citation><mixed-citation xml:lang="en">Komissarova OG, Abdullaev RYu, Aleshina SV. Approaches to selection of optimal chemotherapy regimens in tuberculosis patients with concurrent diabetes mellitus. Tuberculosis and Lung Diseases. 2023; 101(5):31–35 (In Russ.). DOI: https://doi.org/10.58838/2075-1230-2023-101-5-31-35.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Al-Bari MAA, Peake N, Eid N. Tuberculosis-diabetes comorbidities: Mechanistic insights for clinical considerations and treatment challenges. World Journal of Diabetes. 2024;15(5):853–866. DOI: https://doi.org/10.4239/wjd.v15.i5.853.</mixed-citation><mixed-citation xml:lang="en">Al-Bari MAA, Peake N, Eid N. Tuberculosis-diabetes comorbidities: Mechanistic insights for clinical considerations and treatment challenges. World Journal of Diabetes. 2024;15(5):853–866. DOI: https://doi.org/10.4239/wjd.v15.i5.853.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">van Crevel R, Critchley JA. The interaction of diabetes and tuberculosis: Translating research to policy and practice. Tropical Medicine and Infectious Disease. 2021;6(1):8. DOI: https://doi.org/10.3390/tropicalmed6010008.</mixed-citation><mixed-citation xml:lang="en">van Crevel R, Critchley JA. The interaction of diabetes and tuberculosis: Translating research to policy and practice. Tropical Medicine and Infectious Disease. 2021;6(1):8. DOI: https://doi.org/10.3390/tropicalmed6010008.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Tulu B, Amsalu E, Zenebe Y, Abebe M, Fetene Y, Agegn M, et al. Diabetes mellitus and HIV infection among active tuberculosis patients in Northwest Ethiopia: Health facility-based cross-sectional study. Tropical Medicine and Health. 2021;49(1):68. DOI: https://doi.org/10.1186/s41182-021-00358-4.</mixed-citation><mixed-citation xml:lang="en">Tulu B, Amsalu E, Zenebe Y, Abebe M, Fetene Y, Agegn M, et al. Diabetes mellitus and HIV infection among active tuberculosis patients in Northwest Ethiopia: Health facility-based cross-sectional study. Tropical Medicine and Health. 2021;49(1):68. DOI: https://doi.org/10.1186/s41182-021-00358-4.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Niazi AK, Kalra S. Diabetes and tuberculosis: A review of the role of optimal glycemic control. Journal of Diabetes and Metabolic Disorders. 2012;11(1):28. DOI: https://doi.org/10.1186/2251-6581-11-28.</mixed-citation><mixed-citation xml:lang="en">Niazi AK, Kalra S. Diabetes and tuberculosis: A review of the role of optimal glycemic control. Journal of Diabetes and Metabolic Disorders. 2012;11(1):28. DOI: https://doi.org/10.1186/2251-6581-11-28.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Cáceres G, Calderon R, Ugarte-Gil C. Tuberculosis and comorbidities: Treatment challenges in patients with comorbid diabetes mellitus and depression. Therapeutic Advances in Infectious Disease. 2022;9:20499361221095831. DOI: https://doi.org/10.1177/20499361221095831.</mixed-citation><mixed-citation xml:lang="en">Cáceres G, Calderon R, Ugarte-Gil C. Tuberculosis and comorbidities: Treatment challenges in patients with comorbid diabetes mellitus and depression. Therapeutic Advances in Infectious Disease. 2022;9:20499361221095831. DOI: https://doi.org/10.1177/20499361221095831.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Esmail A, Sabur NF, Okpechi I, Dheda K. Management of drug-resistant tuberculosis in special sub-populations including those with HIV co-infection, pregnancy, diabetes, organ-specific dysfunction, and in the critically ill. Journal of Thoracic Disease. 2018;10(5):3102–3118. DOI: https://doi.org/10.21037/jtd.2018.05.11.</mixed-citation><mixed-citation xml:lang="en">Esmail A, Sabur NF, Okpechi I, Dheda K. Management of drug-resistant tuberculosis in special sub-populations including those with HIV co-infection, pregnancy, diabetes, organ-specific dysfunction, and in the critically ill. Journal of Thoracic Disease. 2018;10(5):3102–3118. DOI: https://doi.org/10.21037/jtd.2018.05.11.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Antonio-Arques V, Franch-Nadal J, Caylà JA. Diabetes and tuberculosis: A syndemic complicated by COVID-19. Medicina Clinica (English Edition). 2021;157(6):288–293. DOI: https://doi.org/10.1016/j.medcle.2021.04.006.</mixed-citation><mixed-citation xml:lang="en">Antonio-Arques V, Franch-Nadal J, Caylà JA. Diabetes and tuberculosis: A syndemic complicated by COVID-19. Medicina Clinica (English Edition). 2021;157(6):288–293. DOI: https://doi.org/10.1016/j.medcle.2021.04.006.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Pearson F, Huangfu P, McNally R, Pearce M, Unwin N, Critchley JA. Tuberculosis and diabetes: Bidirectional association in a UK primary care data set. Journal of Epidemiology and Community Health. 2019; 73(2):142–147. DOI: https://doi.org/10.1136/jech-2018-211231.</mixed-citation><mixed-citation xml:lang="en">Pearson F, Huangfu P, McNally R, Pearce M, Unwin N, Critchley JA. Tuberculosis and diabetes: Bidirectional association in a UK primary care data set. Journal of Epidemiology and Community Health. 2019; 73(2):142–147. DOI: https://doi.org/10.1136/jech-2018-211231.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Oliveira Hashiguchi L, Cox SE, Edwards T, Castro MC, Khan M, Liverani M. How can tuberculosis services better support patients with a diabetes co-morbidity? A mixed methods study in the Philippines. BMC Health Services Research. 2023;23(1):1027. DOI: https://doi.org/10.1186/s12913-023-10015-7.</mixed-citation><mixed-citation xml:lang="en">Oliveira Hashiguchi L, Cox SE, Edwards T, Castro MC, Khan M, Liverani M. How can tuberculosis services better support patients with a diabetes co-morbidity? A mixed methods study in the Philippines. BMC Health Services Research. 2023;23(1):1027. DOI: https://doi.org/10.1186/s12913-023-10015-7.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Zhao L, Gao F, Zheng C, Sun X. The impact of optimal glycemic control on tuberculosis treatment out-comes in patients with diabetes mellitus: Systematic review and meta-analysis. JMIR Public Health and Surveillance. 2024;10: e53948. DOI: https://doi.org/10.2196/53948.</mixed-citation><mixed-citation xml:lang="en">Zhao L, Gao F, Zheng C, Sun X. The impact of optimal glycemic control on tuberculosis treatment out-comes in patients with diabetes mellitus: Systematic review and meta-analysis. JMIR Public Health and Surveillance. 2024;10: e53948. DOI: https://doi.org/10.2196/53948.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Milice DM, Macicame I, L Peñalvo J. The collaborative framework for the management of tuberculosis and type 2 diabetes syndemic in low- and middle-income countries: A rapid review. BMC Public Health. 2024; 24(1):738. DOI: https://doi.org/10.1186/s12889-024-18256-9.</mixed-citation><mixed-citation xml:lang="en">Milice DM, Macicame I, L Peñalvo J. The collaborative framework for the management of tuberculosis and type 2 diabetes syndemic in low- and middle-income countries: A rapid review. BMC Public Health. 2024; 24(1):738. DOI: https://doi.org/10.1186/s12889-024-18256-9.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Komissarova OG, Abdullaev RYu, Konyaeva OO, Berezhnaya OO, Mikhaylovskiy AM. Tuberculosis prevalence, symptoms and treatment efficacy in diabetes patients. Vrach. 2017;(2):24–28. (In Russ.). EDN: https://elibrary.ru/YICFFF.</mixed-citation><mixed-citation xml:lang="en">Komissarova OG, Abdullaev RYu, Konyaeva OO, Berezhnaya OO, Mikhaylovskiy AM. Tuberculosis prevalence, symptoms and treatment efficacy in diabetes patients. Vrach. 2017;(2):24–28. (In Russ.). EDN: https://elibrary.ru/YICFFF.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Workneh MH, Bjune GA, Yimer SA. Prevalence and associated factors of tuberculosis and diabetes mellitus comorbidity: A systematic review. PLoS One. 2017;12(4):0175925. DOI: https://doi.org/10.1371/journal.pone.0175925.</mixed-citation><mixed-citation xml:lang="en">Workneh MH, Bjune GA, Yimer SA. Prevalence and associated factors of tuberculosis and diabetes mellitus comorbidity: A systematic review. PLoS One. 2017;12(4):0175925. DOI: https://doi.org/10.1371/journal.pone.0175925.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Dousa KM, Hamad A, Albirair M, Al Soub H, Elzouki AN, Alwakeel MI, et al. Impact of diabetes mellitus on the presentation and response to treatment of adults with pulmonary tuberculosis in Qatar. Open Forum Infectious Diseases. 2018;6(1): ofy335. DOI: https://doi.org/10.1093/ofid/ofy335.</mixed-citation><mixed-citation xml:lang="en">Dousa KM, Hamad A, Albirair M, Al Soub H, Elzouki AN, Alwakeel MI, et al. Impact of diabetes mellitus on the presentation and response to treatment of adults with pulmonary tuberculosis in Qatar. Open Forum Infectious Diseases. 2018;6(1): ofy335. DOI: https://doi.org/10.1093/ofid/ofy335.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Critchley JA, Carey IM, Harris T, DeWilde S, Hosking FJ, Cook DG. Glycemic control and risk of infections among people with type 1 or type 2 diabetes in a large primary care cohort study. Diabetes Care. 2018; 41(10):2127–2135. DOI: https://doi.org/10.2337/dc18–0287.</mixed-citation><mixed-citation xml:lang="en">Critchley JA, Carey IM, Harris T, DeWilde S, Hosking FJ, Cook DG. Glycemic control and risk of infections among people with type 1 or type 2 diabetes in a large primary care cohort study. Diabetes Care. 2018; 41(10):2127–2135. DOI: https://doi.org/10.2337/dc18–0287.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Sotgiu G, Centis R, D’ambrosio L, Migliori GB. Tuberculosis treatment and drug regimens. Cold Spring Harbor Perspectives in Medicine. 2015;5(5): a017822. DOI: https://doi.org/10.1101/cshperspect.a017822.</mixed-citation><mixed-citation xml:lang="en">Sotgiu G, Centis R, D’ambrosio L, Migliori GB. Tuberculosis treatment and drug regimens. Cold Spring Harbor Perspectives in Medicine. 2015;5(5): a017822. DOI: https://doi.org/10.1101/cshperspect.a017822.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
